BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4808437)

  • 1. Antiparkinsonian agents and depot phenothiazine.
    Chien CP; Dimascio A; Cole JO
    Am J Psychiatry; 1974 Jan; 131(1):86-90. PubMed ID: 4808437
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug monitoring at an Australia depot phenothiazine clinic.
    Marriott P; Hiep A
    J Clin Psychiatry; 1978 Mar; 39(3):206-12. PubMed ID: 580271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiparkinsonian agents and fluphenazine decanoate.
    Idzorek S
    Am J Psychiatry; 1976 Jan; 133(1):80-2. PubMed ID: 1247126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid "digitalization" of decompensated schizophrenic patients with antipsychotic agents.
    Donlon PT; Tupin JP
    Am J Psychiatry; 1974 Mar; 131(3):310-2. PubMed ID: 4812695
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C; Dimascio A; Demirgian E
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract]   [Full Text] [Related]  

  • 6. Depot phenothiazine treatment in acute psychosis: a sequential comparative clinical study.
    Chien CP; Cole JO
    Am J Psychiatry; 1973 Jan; 130(1):13-8. PubMed ID: 4566388
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate.
    Gelenberg AJ; Doller JC; Schooler NR; Mieske M; Severe J; Mandel MR
    Am J Psychiatry; 1979 Feb; 136(2):217-9. PubMed ID: 367182
    [No Abstract]   [Full Text] [Related]  

  • 8. The depot fluphenazines: a reappraisal after 10 years' clinical experience.
    Ayd FJ
    Am J Psychiatry; 1975 May; 132(5):491-500. PubMed ID: 1091162
    [No Abstract]   [Full Text] [Related]  

  • 9. Side effects of depot fluphenazines.
    Ayd FJ
    Adv Biochem Psychopharmacol; 1974; 9(0):301-9. PubMed ID: 4599435
    [No Abstract]   [Full Text] [Related]  

  • 10. A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent.
    Dom R; Van Lommel R; Baro F
    Acta Psychiatr Scand; 1971; 47(4):399-410. PubMed ID: 4947805
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed severe extrapyramidal disturbance following frequent depot phenothiazine administration.
    Warner AM; Wyman SM
    Am J Psychiatry; 1975 Jul; 132(7):743-5. PubMed ID: 1137022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benztropine psychosis.
    Ananth JV; Jain RC
    Can Psychiatr Assoc J; 1973 Oct; 18(5):409-14. PubMed ID: 4746144
    [No Abstract]   [Full Text] [Related]  

  • 13. The withdrawal of benztropine mesylate in chronic schizophrenic patients.
    Baker LA; Cheng LY; Amara IB
    Br J Psychiatry; 1983 Dec; 143():584-90. PubMed ID: 6362765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiparkinsonian medication withdrawal in the treatment of tardive dyskinesia: a report of three cases.
    Yassa R
    Can J Psychiatry; 1985 Oct; 30(6):440-2. PubMed ID: 4063942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenothiazine-induced decompensation.
    Van Putten T; Mutalipassi LR; Malkin MD
    Arch Gen Psychiatry; 1974 Jan; 30(1):102-5. PubMed ID: 4587065
    [No Abstract]   [Full Text] [Related]  

  • 16. Noncompliance with antiparkinsonian medications in neuroleptic-treated schizophrenic patients: three cases of an unreported phenomenon.
    Bermanzohn PC; Siris SG
    J Clin Psychiatry; 1994 Nov; 55(11):488-91. PubMed ID: 7989282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrapyramidal symptoms in the course of fluphenazine treatment.
    Bastecký J; Vinar O; Taussigová D
    Act Nerv Super (Praha); 1972; 14(2):97-9. PubMed ID: 5040184
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of outpatients with high doses of haloperidol].
    Shopsin B; Kline N
    Acta Psiquiatr Psicol Am Lat; 1981 Jul; 27(3):236-42. PubMed ID: 7348083
    [No Abstract]   [Full Text] [Related]  

  • 19. Practical considerations in the use of depot neuroleptics for the treatment of schizophrenia.
    Johnson DA
    Br J Hosp Med; 1977 Jun; 17(6):546-58. PubMed ID: 18242
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton].
    Kammerer T; Schweitzer-Bucher E; Jamet P; Royer M
    Ann Med Psychol (Paris); 1972 May; 1(5):688-96. PubMed ID: 5081112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.